NASDAQ: PODDInsulet Corp Stock
$265.47-2.11 (-0.79%)
Updated Dec 6, 2024
PODD Price
$265.47
Fair Value Price
-$62.03
Market Cap
$18.62B
52 Week Low
$160.19
52 Week High
$279.40
P/E
44.1x
P/B
16.66x
P/S
8.23x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.98B
Earnings
$420.90M
Gross Margin
69.4%
Operating Margin
17.01%
Profit Margin
21.2%
Debt to Equity
1.71
Operating Cash Flow
$328M
Beta
0.94
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PODD Overview
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PODD's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Value
C
Growth
C
Momentum
C
Sentiment
C
Safety
B
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important PODD news, forecast changes, insider trades & much more!
PODD News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PODD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PODD ($265.47) is overvalued by 527.97% relative to our estimate of its Fair Value price of -$62.03 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
PODD ($265.47) is not significantly undervalued (527.97%) relative to our estimate of its Fair Value price of -$62.03 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
PODD is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more PODD due diligence checks available for Premium users.
Valuation
PODD fair value
Fair Value of PODD stock based on Discounted Cash Flow (DCF)
Price
$265.47
Fair Value
-$62.03
Undervalued by
527.97%
PODD ($265.47) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
PODD ($265.47) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
PODD is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
PODD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
44.1x
Industry
36.83x
Market
29.86x
PODD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PODD is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
PODD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
16.66x
Industry
4.05x
PODD is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PODD's financial health
Profit margin
Revenue
$543.9M
Net Income
$77.5M
Profit Margin
14.2%
PODD's Earnings (EBIT) of $337.40M... subscribe to Premium to read more.
Interest Coverage Financials
PODD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$3.0B
Liabilities
$1.9B
Debt to equity
1.71
PODD's short-term assets ($1.86B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PODD's short-term assets ($1.86B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PODD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PODD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$98.5M
Investing
-$29.3M
Financing
$7.8M
PODD's operating cash flow ($327.80M)... subscribe to Premium to read more.
Debt Coverage Financials
PODD vs Medical Device Stocks
Insulet Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.